Quarterly Balance Sheet

Carna Biosciences, Inc. - Filing #7595165

Concept As at
2022-06-30
As at
2021-12-31
Quarterly balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
4,684,699,000 JPY
3,817,834,000 JPY
Merchandise and finished goods
79,470,000 JPY
72,514,000 JPY
Work in process
6,208,000 JPY
7,521,000 JPY
Raw materials and supplies
27,502,000 JPY
30,453,000 JPY
Other
130,492,000 JPY
146,324,000 JPY
Current assets
5,058,259,000 JPY
5,318,487,000 JPY
Non-current assets
Property, plant and equipment
80,560,000 JPY
51,574,000 JPY
Property, plant and equipment
Intangible assets
2,326,000 JPY
2,738,000 JPY
Intangible assets
Investments and other assets
77,068,000 JPY
59,760,000 JPY
Investments and other assets
Non-current assets
159,955,000 JPY
114,073,000 JPY
Assets
5,218,214,000 JPY
5,432,560,000 JPY
Liabilities
Current liabilities
Income taxes payable
22,849,000 JPY
24,236,000 JPY
Other
52,380,000 JPY
200,794,000 JPY
Current liabilities
485,098,000 JPY
774,655,000 JPY
Non-current liabilities
Bonds payable
18,000,000 JPY
32,000,000 JPY
Long-term borrowings
208,396,000 JPY
268,390,000 JPY
Asset retirement obligations
37,737,000 JPY
37,434,000 JPY
Other
43,035,000 JPY
4,508,000 JPY
Non-current liabilities
307,169,000 JPY
342,332,000 JPY
Liabilities
792,267,000 JPY
1,116,988,000 JPY
Net assets
Shareholders' equity
Share capital
1,231,110,000 JPY
1,056,953,000 JPY
Capital surplus
4,982,320,000 JPY
4,808,163,000 JPY
Retained earnings
-1,932,071,000 JPY
-1,572,951,000 JPY
Treasury shares
-222,000 JPY
-222,000 JPY
Shareholders' equity
4,281,137,000 JPY
4,291,942,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-1,871,000 JPY
-630,000 JPY
Deferred gains or losses on hedges
94,178,000 JPY
6,578,000 JPY
Valuation and translation adjustments
136,811,000 JPY
13,789,000 JPY
Share acquisition rights
7,999,000 JPY
9,840,000 JPY
Net assets
4,425,947,000 JPY
4,315,572,000 JPY
Liabilities and net assets
5,218,214,000 JPY
5,432,560,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.